Mutagenic and carcinogenic potential of menadione

Neoplasma

Volumn 53, Issue 4, 2006, Pages 316-323

  Cojocel, C ^a   Novotny, L ^a   Vachalkova, A ^b  

^a KUWAIT UNIVERSITY   (Kuwait)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Alkaline elution; Carcinogenicity; Menadione; Mutagenicity; Polarography; Single stranded DNA; UDS test

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; MENADIONE; N,N DIMETHYLFORMAMIDE; S 9; SUPEROXIDE; THIOCTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CARCINOGENICITY; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DOSE RESPONSE; ELUTION; GENOTOXICITY; HUMAN; HUMAN CELL; MALE; METABOLIC ACTIVATION; MUTAGENICITY; NONHUMAN; OXIDATIVE STRESS; POLAROGRAPHY; RAT; UNSCHEDULED DNA SYNTHESIS;

EID: 33746277559     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. ALARCON QM, VASQUEZ F, ACOSTAA, BURGUERA GL, ORTEGA SY. Hematologic changes in rats treated with high doses of Vitamin K3. Ach Latinoam Nutr 1991; 41: 363-374.
2. MUNDAY R, SMITH BL, MUNDAY CM. Toxicity of 2,3-dialkyl-1,4- naphthoquinones in rats: comparison with cytotoxicity in vitro. Free Radic Biol Med 1995; 19: 759-765.
3. VASILIOU V, QAMAR L, PAPPA A, SOPHOS NA, PETERSON DR. Involvement of electrophile responsive element and p53 in the activation of hepatic stellate cells as response to electrophile menadione. Arch Biochem Biophys 2003; 413: 164-171.
4. SMITH MT. Quinones as mutagenes, carcinogens, and anticancer agents: introduction and overview. J Toxicol Environ Health 1985; 16: 665-672.
5. SIDOROVA YA, GRISHANOVA AY, LYAKHOVICH W. Rat hepatic CYP1A1 and CYP1A2 induction by menadione. Toxicol Lett 2005; 155: 253-258.
6. VON GRUENIGEN VE, JAMISON JM, GILLOTEAUX J, LORIMER HE, SUMMERS M et al. The in vitro antitumor activity of vitamins C andK3 against ovarian carcinoma. Anticancer Res 2003; 23: 3279-3287.
7. NUNOSHIBA T, DEMPLE B. Potent intracellular oxidative stress exerted by the carcinogen 4-nitroquinoline-N-oxide. Cancer Res 1993; 53: 3250-3252.
8. YAMAMOTO K, INOUE S, KAWANISHi S. Site-specific DNA damage and 8-hydroxydeoxyguanosine formation by hydroxylamine and 4-hydroxyaminoquinoline 1-oxide in the presence of Cu (II): role of active oxygen species. Carcinogenesis 1993; 14: 1397-1401.
9. RIDDICK JA, BUNGER WB. In: A. Weissberger, editor. Organic solvents, Vol. II. N,N-dimethylformarnid. New York, Wiley-Interscience 1970: 836-840.
10. NOVOTNY L, VACHALKOVA A. Some electrochemical characteristics of synthetic analogs of nucleic acid components. I. Derivates of cytidine and arabinosylcytosine. An attempt to find correlation among some of their properties. Neoplasma 1990; 37: 377-386.
11. VACHALKOVAA, NOVOTNY L. Polarographic testing of cardnogenicity of some chemotherapeutics. Neoplasma 1997; 44: 389-394.
12. NETTER KJ. A method for the direct measurement of O-demethylation in liver microsomes and its use in studying microsome inhibition by SKF-525-A. Naunyn-Schmiedebergs Arch Exp Path Pahrmacol 1960; 238: 292-300.
13. ORRENIUS S, ERNSTER, L. Interaction between liver microsomes and compounds capable of undergoing enzymic hydroxylation. Life Sci 1967; 6: 1473-1482.
14. DENT JG, GRAICHEN ME, SCHNELL S, LASKER J. Constitutive and induced hepatic microsomal cytochrome P-450 monooxygenase activities in male Fischer-344 and CD rats A comparative study. Toxicol Appl Pharmacol 1980; 52: 45-53.
15. SCHACTERLE GR, POLLACK RL. A simplified method for the quantitative assay of small amounts of protein in biologic material. Anal Biochem 1973; 51: 654-655.
16. MASSEY V. The microestimation of succinate and the extinction coefficient of cytochrome c. Biochim Biophys Acta 1959; 34: 255-256.
17. AZZI A, MONTECUCCO C, RICHTER C. The use of acetylated ferrycytochrome c for the detection of superoxide radicals produced in biological membranes. Biochem Biophys Res Commun 1975; 65: 597-603.
18. GIARD DJ, AARONSON SA, TODARO GJ, AMSTEIN P, KERSEY JH et al In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 1973; 51: 1417-1423.
19. MARTIN CN, MCDERMID AC, GARNER RC. Testing of known carcinogens and noncarcinogenes for their ability to induce unscheduled DNA synthesis in HeLA cells. Cancer Res 1978; 38: 2621-2727.
20. OECD Guideline for Testing of Chemical Genetic Toxicology. DNA Damage and Repair/Unscheduled DNA Synthesis in Mammalian Cells in Vitro 1986; 482: 1-6.
21. MITCHELL AD, CASCIANO DA, MELLZ ML, ROBINSON DE, SAN RHC et al. Unscheduled DNA synthesis test: a report of the U.S. Environmental Protection Agency Gene Tox Program. Mutation Res 1983; 123: 363-410.
22. MARON DM, AMES BN. Revised methods for the Salmonella mutagenicity test. Mutation Res 1983: 113: 173-215.
23. COJOCEL C, NOVOTNY L, VACHALKOVA A, KNAUF B. Comparison of the carcinogenic potential of streptozotocin by polarography and alkaline elution. Neoplasma 2003; 50: 110-116.
24. HINEGARDNER RT. An improved fluorometric assay for DNA. Anal Biochem 1971; 39: 197-201.
25. GABELOVA A, SLAMENOVA D, RUZEKOVA L, FARKASOVA T, HORVATHOVA E. Measurement of DNA strand breakage and DNA repair induced with hydrogen peroxide using single cell gel electrophoresis, alkaline DNA unwinding and alkaline elution of DNA. Neoplasma 1997; 44(6): 380-388.
26. TYSON CK, MIRSALIS JC. Measurement of unscheduled DNA synthesis in rat kidney cells following in vivo treatment with genotoxic agents. Environ Mutagen 1985; 7: 889-899.
27. JUNG R, COJOCEL C, MULLER W, BOTGER D, LUCK E. Evaluation of the toxic potential of sorbic acid and potassium sorbate. Fd Chem Toxic 1992; 30: 1-7.
28. MULLER W, COJOCEL C, KRAMER W, MAYER, D. Absence of genotoxic activity of penbutolol in bacterial and mammalian cell screening systems. Mutation Res 1990; 242: 135-142.
29. FUNATO K, MIYAZAWA K, YAGUCHI M, GOTOH A, OHYASHIKI K. Combination of 22-oxa-1,25-dihydroxyvitamin D(3), a vitamin D(3) derivative, with vitamin K(2) (VK2) synergistically enhances cell differentiation but suppresses VK2-inducing apoptosis in HL-60cells. Leukemia 2002; 16(8): 1519-1527.
30. GELBOIN HV. Benzo[a]pyrene metabolism, activation and carcinogenesis. Role and egulation of mixed-function oxidases and related enzymes. Physiol Rev 1980; 60: 1107-1166.
31. AMES BN, MCCANN J, YAMASAKI E. Methods for detecting carcinogenesis and mutagenesis with the Salmonella/mammalian microsome mutagenecity tests. Mutation Res 1975; 31: 347-364
32. WILLS ED. Effects of vitamin K and naphthoquinones on lipid peroxide formation and oxidative demethylation by liver microsomes. Biochem Pharmacol 1972; 21: 1879-1883.
33. GALIEGUE-ZOUITINA S, BAILLEUL B, GINOT YM, PERLY B, VIGNY P, LOUCHEUX-LEFEBRE MH. N2-guanyl and N6-adenylarylation of chicken erythrocyte DNA by the ultimate carcinogen 4-nitroquinoline 1-oxide. Cancer Res 1986; 46(4): 1858-1863.
34. SUGIMURA T, OKABE K, NAGAO M. The metabolism of 4-nitroquinoline-1-oxide, a carcinogen. 3. An enzyme catalyzing the conversion of 4-nitroquinolie-1-oxide to 4-hydroxyaminoquinoline-1- oxide in rat liver and hepatomas. Cancer Res 1966; 26(8): 1717-1721.
35. KOHDA K, TADA M, KASAI H, NISHIMURA S, KAWAZOE Y. Formating of 8-hydroxyguanine residues in cellular DNA exposed to the carcinogen 4-nitroquinoline 1-oxide. Biochem Res Commun 1986; 139(2): 626-632.
36. NOTO V, TAPER HS, JIANG YH, JANSSENS J, BONTE J, DE LOECKER W. Effects of sodium ascorbate (vitamin C) and 2-methyl 1,4-naphthoquinone (vitamin K3) treatment on human tumor cell growth in vitro. I. Synergism of combined vitamin C and K3 action. Cancer 1989; 63: 901-906.
37. WAXMAN S, BRUCKNER H. The enhancement of 5-fluorouracil anti-metabolic activity by leucovorin, menadione and alpha-tocopherol. Eur J Cancer Clin Oncol 1982; 18: 685-692.
38. NUTTER LM, CHENG AL, HUNG HL, HSICH RK, NGO EO, LIU TW. Menadione: spectrum of anticancer activity and effects on nucleotide metabolism in human neoplastic cell lines. Biochem Pharmacol 1991; 41: 1283-1292.
39. GOLD J. In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals. Cancer Treat Rep 1986; 70: 1433-1435.
40. ONRUST H, WOSTMANN B. Rec Trav Chim 1950; 69: 1207.
41. In: J. Prozst, V. Cielszki, K. Gyorbiro: Polarographie mit besonderer berucksichtigung der klassischen Methoden. Akademiai Kiado, Budapest 1967: 445-446.
42. MNOUCEK K. Contribution to polarographic and spectral studies of water-soluble vitamine K3 (menadione-natrium-bisulfite). Ceskoslovenska farmacie 1970; XIX (4): 133-138 (in Czech).
43. HITOMI M, NONOMURA T, YOKOYAMA F, YOSHIJI H, OGAWA M et al. In vitro and in vivo antitumor effects of vitamin K5 on hepatocellular carcinoma. Int J Oncol 2005; 26: 1337-1344.
44. GANT TW, RAO DN, MASON RP, COHEN GM. Redox Cycling and sulphydryl acrylation; their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem Biol Interact 1988; 65: 157-173.
45. NISHIKAWA Y, CARR BI, WANG M, WANG M, KAR S et al. Growth inhibition of hepatoma cells induced by vitamin K and its analogs. J Biol Chem 1995; 270: 28304-28310.
46. BROWN PC, DULIK DM, JONES TW. The toxicity of menadione (2-methyl-1,4-naphthoqumone) and two thioether conjugates studied with isolated renal epithelial cells. Arch Biochem Biophys 1991: 285: 187-196.
47. NUTTER LM, NGO EO, FISHER GR, GUTIERREZ PL. DNA Strand scission and free radical production in menadione-treated cells. Correlation with cytotoxicity and role of NADPH quinone acceptor oxidoreductase. J Biol Chem 1992; 267: 2474-2479.
48. ROSS D, THOR H, THREADGILL MD, SANDY MS, SMITH M et al. The role of oxidative processes in the cytotoxicity of substituted 1,4-naphthoquinones in isolated hepatocytes. Arch Biochem Biophys 1986; 248: 460-466.
49. NIEMCZYK E, MAJCZAK A, HALLMANN A, KEDZIOR J, WOZNIAK M, WAKABAYASHI T. A possible involvement of plasma membrane NAD(P)H oxidase in the switch mechanism of the cell death mode from apoptosis to necrosis in menadione-induced cell injury. Acta Biochim Pol 2004; 51(4): 1015-1022.
50. CARICCHIO R, KOVALENKO D, KAUFMANN WK, COHEN PL. Apoptosis provoked by the oxidative stress inducer menadione (Vitamin K(3)) is mediated by the Fas/Fas ligand system. Clin Immunol 1999; 93: 65-74.
51. BOUCHARD C, STALLER P, EILERS M. Control of cell proliferation by Myc. Trends Cell Biol 1998; 8: 202-206.
52. COLE MD, MCMAHON SB. The Myc oncoprotein: a critical evaluation of transactivation and target gene regulation. Oncogene 1999; 18: 2916-2924.
53. JAMISON JM, GILLOTEAUX J, NASSIRI MR, VENUGOPAL M, NEAL DR, SUMMERS JL. Cell cycle arrest and autoschizis in a human bladder carcinoma cell line following Vitamin C and Vitamin K3 treatment. Biochem Pharmacol 2004; 67: 337-351.
54. WU FY, SUN TP. Vitamin K3 induces cell cycle arrest and cell death by inhibiting Cdc25 phosphatase. Eur J Cancer 1999; 35: 1388-1393.
55. WU FY, CHANG NT, CHEN WJ, JUAN CC. Vitamin K3-induced cell cycle arrest and apoptotic cell death are accompanied by altered expression of c-fos and c-myc in nasopharyngeal carcinoma cells. Oncogene 1993; 8: 2237-2244.